photo of

Details

Role Theme Director
Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal Children’s Hospital Melbourne and Professorial Research Fellow at the University of Melbourne. Andrew is Co-Chair of Melbourne Children’s Global Health. He is a Fellow of the Australian Academy of Health and Medical Sciences.

Andrew did the majority of his medical training at the Royal Children’s Hospital Melbourne. Andrew moved to Suva, Fiji, in 2005 where he conducted research towards his PhD (University of Melbourne). Subsequently, he completed his subspecialty training in paediatric infectious diseases at British Columbia Children’s Hospital in Vancouver, Canada, before returning to Melbourne in 2010.

Andrew’s research focuses on tropical diseases, particularly scabies, Strep A and rheumatic heart disease. He is Director of the World Scabies Program, recipient of the Macquarie 50th Anniversary Award, and Director of the World Health Organisation Collaborating Centre on Scabies Control. Andrew is Co-Director of the Australian Strep A Vaccine Initiative, Co-Chair of the Strep A Vaccine Global Consortium, and President of the Lancefield International Society for Streptococci and Streptococcal Diseases.

Andrew has won several awards including the inaugural Jian Zhou Medal awarded by the Australian Academy of Health and Medical Sciences in 2020, and the Bailey K Ashford Medal awarded by the American Society of Tropical Medicine and Hygiene in 2020.
Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal...
Professor Andrew Steer is Director of Infection, Immunity and Global Health, and Group Leader of the Tropical Diseases Research Group, at the Murdoch Children’s Research Institute. He is a paediatric infectious diseases physician at the Royal Children’s Hospital Melbourne and Professorial Research Fellow at the University of Melbourne. Andrew is Co-Chair of Melbourne Children’s Global Health. He is a Fellow of the Australian Academy of Health and Medical Sciences.

Andrew did the majority of his medical training at the Royal Children’s Hospital Melbourne. Andrew moved to Suva, Fiji, in 2005 where he conducted research towards his PhD (University of Melbourne). Subsequently, he completed his subspecialty training in paediatric infectious diseases at British Columbia Children’s Hospital in Vancouver, Canada, before returning to Melbourne in 2010.

Andrew’s research focuses on tropical diseases, particularly scabies, Strep A and rheumatic heart disease. He is Director of the World Scabies Program, recipient of the Macquarie 50th Anniversary Award, and Director of the World Health Organisation Collaborating Centre on Scabies Control. Andrew is Co-Director of the Australian Strep A Vaccine Initiative, Co-Chair of the Strep A Vaccine Global Consortium, and President of the Lancefield International Society for Streptococci and Streptococcal Diseases.

Andrew has won several awards including the inaugural Jian Zhou Medal awarded by the Australian Academy of Health and Medical Sciences in 2020, and the Bailey K Ashford Medal awarded by the American Society of Tropical Medicine and Hygiene in 2020.

Top Publications

  • McGregor, R, Paterson, A, Sharma, P, Chen, T, Lovell, JR, Carlton, LH, Steer, AC, Osowicki, J, Loh, JMS, Moreland, NJ. Naturally acquired functional antibody responses to group A Streptococcus differ between major strain types. mSphere 8(5) : e00179 -e00123 2023
    view publication
  • Le, B, Clarke, NE, Hii, SF, Byrne, A, Khattak, A, Lake, S, Lazu, E, Wickham, S, Wand, H, Olsen, N, et al. Effectiveness of one and two doses of ivermectin mass drug administration in reducing the prevalence and intensity of soil-transmitted helminth (STH) infections in Western Province, Solomon Islands: a cluster-randomised, before-after analysis. The Lancet Regional Health - Western Pacific 100942 2023
    view publication
  • Asturias, EJ, Excler, J-L, Ackland, J, Cavaleri, M, Fulurija, A, Long, R, McCulloch, M, Sriskandan, S, Sun, W, Zühlke, L, et al. Safety of Streptococcus pyogenes Vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring. Clinical Infectious Diseases 77(6) : 917 -924 2023
    view publication
  • Abo, Y-N, Jamrozik, E, McCarthy, JS, Roestenberg, M, Steer, AC, Osowicki, J. Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy. The Lancet Infectious Diseases 2023
    view publication
  • Abo, Y-N, Oliver, J, McMinn, A, Osowicki, J, Baker, C, Clark, JE, Blyth, CC, Francis, JR, Carr, J, Smeesters, PR, et al. Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges. The Lancet Regional Health - Western Pacific 100873 2023
    view publication

Page 1 of 63